Association between transitory increase in PTH following denosumab administration and reduced intracortical porosity is a distinctive attribute of denosumab therapy
E. Seeman; C. Libanati; M. Austin; R. Chapurlat⁎; S. Boyd; R. Zebaze; D. Hanley; J. Zanchetta; A. Grauer; J. Bilezikian
- 作者E. Seeman; C. Libanati; M. Austin; R. Chapurlat⁎; S. Boyd; R. Zebaze; D. Hanley; J. Zanchetta; A. Grauer; J. Bilezikian
- 卷第50卷
- 印刷ISSN8756-3282
- 文件大小130.37KB
- 发表时间2012
- DOI10.1016/j.bone.2012.02.507